Skip to main content
Main menu
About Us
Mission, Purpose & Impact
Board
Committees
Staff
Membership
Emerging Research Institutions Pilot
History
Year in Review
Media
Policy Issues
Reducing Red Tape
Financial Management & Compliance
Audit
F&A
Other Post Award
Intellectual Property & Innovation
Bayh-Dole & iEdison
Intellectual Property Rights
Other Intellectual Property & Innovation
Proposals & Awards
Contracting Issues
Disclosure Requirements
Proposals & Award Policies
Uniform Guidance
Other Proposal & Award Issues
Research Compliance
Animal Subjects
Biosafety & Related Research Issues
Cannabis/Controlled Substances
Conflict of Interest/Commitment
Human Subjects
Research Integrity & Misconduct
Other Research Compliance
Science & Security
Cybersecurity
Export Controls
Foreign Contract & Gift Reporting
Restrictions on Information Transfer
Other Science & Security
Research Data & Access Policies
Data Management & Public Access
Privacy, Confidentiality & Data Security
Other Data & Access Issues
Events
COGR Updates
Latest COGR Update
All COGR Updates
Contact Us
Member Login
Comment Letter
Search
Filters
Type
Comment Letter
Policy Perspective
Archived
External Resource
Event Materials
Statements
COGR Update
Matrices & Trackers
Survey
Topic
Proposals & Awards
Research Compliance
Uniform Guidance
Financial Management & Compliance
Other Post Award
Human Subjects
Contracting Issues
Other Proposal & Award Issues
F&A
Proposals & Award Policies
Conflict of Interest/Commitment
Intellectual Property & Innovation
Other Intellectual Property & Innovation
Other Research Compliance
Research Integrity & Misconduct
Biosafety & Related Research Issues
Data Management & Public Access
Disclosure Requirements
Export Controls
Other Science & Security
Research Data & Access Policies
Science & Security
Apply
Date Published
Oldest First
Newest First
47 results
Archived
Policy Perspective
Comment Letter
Feb 02, 2002
National Science Foundation Revision to Research Misconduct
Document
Research Integrity & Misconduct
Research Compliance
Archived
Policy Perspective
Comment Letter
Jul 20, 2001
Food and Drug Administration Clinical Misconduct Guidance
Document
Research Integrity & Misconduct
Research Compliance
Archived
Comment Letter
Mar 22, 1989
COGR Letter to Prime Reps on Proposed Common Rule to Replace OMB Circular A 110
Human Subjects
Research Compliance
Comment Letter
Archived
Nov 03, 1987
COGR Letter to Jon Glaudemans OMB on Incentives to Control Indirect Costs at Research Universities
Other Post Award
F&A
Financial Management & Compliance
Archived
Comment Letter
Feb 15, 1985
COGR Letter to Prime Reps on Preliminary Study of the Administrative Cost Component of the Indirect Cost Rates of Eight Universities
Other Post Award
F&A
Financial Management & Compliance
Policy Perspective
Archived
Comment Letter
External Resource
COGR's FAQs and Resources on COVID-19's Impact to Federal Awards
Archived
Policy Perspective
External Resource
Statements
Comment Letter
COGR Update
Event Materials
Federal Updates (ARCHIVED)
Pagination
1
2
3
4
5
